Table 3. Model Parameter Values: Quality Weights and Cost.
Base | Min | Max | Source | |
Quality (utilities) a | [10], [30], [31], [32], [33] | |||
Mild chronic HCV (F0, F1) | 0.98 | 0.70 | 1.00 | |
SVR following mild HCV | 1.00 | 0.74 | 1.00 | |
Moderate chronic HCV (F2, F3) | 0.85 | 0.66 | 1.00 | |
SVR following moderate HCV | 0.93 | 0.71 | 1.00 | |
Compensated cirrhosis (F4) | 0.79 | 0.46 | 1.00 | |
SVR following F4 | 0.93 | 0.60 | 1.00 | |
Decompensated cirrhosis | 0.72 | 0.26 | 0.91 | |
HCC | 0.72 | 0.15 | 0.95 | |
Liver transplantb | 0.81 | 0.64 | 1.00 | |
Liver biopsy decrementc | −0.05 | −0.20 | 0 | Assumed |
Treatment decrement (standard treatment)c | −0.11 | −0.20 | 0 | |
Treatment decrement (triple therapy)c | −0.055 | −0.11 | 0 | Assumed |
Cost (2009 USD) | ||||
Screening test | ||||
Liver biopsy | $1,415 | $974 | $1,623 | [8], [34] |
FibroTest (FibroSure) | $236 | $100 | $295 | [8] |
Treatment (peginterferon and ribavirin + medical care) | [10], [35], [38], [41] | |||
No EVR, genotype 1 (12 weeks) | $7,383 | $5,605 | $9,020 | |
SVR, genotype 1 (48 weeks) | $29,530 | $22,420 | $36,080 | |
SVR, genotype 2 and 3 (24 weeks) | $14,765 | $11,812 | $22,950 | |
Treatment (telaprevir drug cost for 12 weeks) | $49,200 | $36,828 | $59,040 | [39], [53] |
Cost of annual cared | [10], [38], [40], [41], [42] | |||
HCV no fibrosis (F0) | $1,610 | $150 | $2,000 | |
HCV portal fibrosis (F1, F2) | $1,610 | $150 | $2,000 | |
HCV bridging fibrosis (F3) | $1,610 | $150 | $2,000 | |
Compensated cirrhosis (F4) | $1,610 | $150 | $2,000 | |
Decompensated cirrhosis (DC) | $10,930 | $5,470 | $16,400 | |
HCC | $43,510 | $21,760 | $65,270 | |
Liver transplant, first year | $143,290 | $71,650 | $214,930 | |
Liver transplant, subsequent | $25,020 | $12,510 | $37,540 |
The quality of life weight for a given age and HCV disease state is computed as the product of the utility associated with the HCV disease state and a mean age-specific quality weight obtained from published data [54], [55].
Assumed the utility in the post liver transplant state is the same as the utility in F0 state.
Unlike other utilities these decrement are short-term—only the time period when the intervention occurs.
Baseline healthcare cost by age is included in the model [56].